These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 4050157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM.
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [Abstract] [Full Text] [Related]

  • 3. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.
    Sherrard DJ, Walker JV, Boykin JL.
    Am J Kidney Dis; 1988 Aug; 12(2):126-30. PubMed ID: 3400633
    [Abstract] [Full Text] [Related]

  • 4. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ, Sharf B, Bell P, Meyers AM.
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [Abstract] [Full Text] [Related]

  • 5. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P, Ralston AJ, Day JP.
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Speech apraxia in dialysis-associated aluminum encephalopathy].
    Haug BA, Botsch G, Felgenhauer K.
    Nervenarzt; 1991 Oct; 62(10):637-40. PubMed ID: 1749454
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993 Oct; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P, Gmeiner R, Beck G, König P.
    Wien Med Wochenschr; 1987 Aug 15; 137(14-15):355-60. PubMed ID: 3673100
    [Abstract] [Full Text] [Related]

  • 10. [The problem of the so-called dialysis encephalopathy].
    Both R, Mühlau G, Neumann J, Sperschneider H, Stein G.
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982 Aug 15; 50():218-24. PubMed ID: 7157117
    [No Abstract] [Full Text] [Related]

  • 11. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A, Poisson M, Masson S, Bleibel JM, Lafforgue B, Raymond P, Jaudon MC.
    Nouv Presse Med; 1978 Jun 10; 7(23):2053-9. PubMed ID: 673773
    [Abstract] [Full Text] [Related]

  • 12. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 13. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb 14; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

  • 14. Aluminum kinetics of the REDY system: a study of the impact of deferoxamine therapy.
    Culpepper CP, Cummings R, Westervelt FB, Savory J, Wills MR.
    Trans Am Soc Artif Intern Organs; 1983 Feb 14; 29():76-80. PubMed ID: 6673321
    [No Abstract] [Full Text] [Related]

  • 15. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb 14; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 16. Aluminum intoxication of bone in renal failure--fact or fiction?
    Malluche HH, Faugere MC, Smith AJ, Friedler RM.
    Kidney Int Suppl; 1986 Feb 14; 18():S70-3. PubMed ID: 3458000
    [No Abstract] [Full Text] [Related]

  • 17. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
    Bournerias F, Monnier N, Dufier JL, Réveillaud RJ.
    Nephrologie; 1987 Feb 14; 8(1):27-9. PubMed ID: 3587485
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P, Day JP.
    Clin Nephrol; 1985 Feb 14; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.